GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OKYO Pharma Ltd (NAS:OKYO) » Definitions » Cyclically Adjusted PB Ratio

OKYO Pharma (OKYO Pharma) Cyclically Adjusted PB Ratio : 11.08 (As of Jun. 04, 2024)


View and export this data going back to 2022. Start your Free Trial

What is OKYO Pharma Cyclically Adjusted PB Ratio?

As of today (2024-06-04), OKYO Pharma's current share price is $1.44. OKYO Pharma's Cyclically Adjusted Book per Share for the fiscal year that ended in Mar23 was $0.13. OKYO Pharma's Cyclically Adjusted PB Ratio for today is 11.08.

The historical rank and industry rank for OKYO Pharma's Cyclically Adjusted PB Ratio or its related term are showing as below:

OKYO' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 19.23
Current: 11

During the past 13 years, OKYO Pharma's highest Cyclically Adjusted PB Ratio was 19.23. The lowest was 0.00. And the median was 0.00.

OKYO's Cyclically Adjusted PB Ratio is ranked worse than
91.16% of 656 companies
in the Biotechnology industry
Industry Median: 1.745 vs OKYO: 11.00

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

OKYO Pharma's adjusted book value per share data of for the fiscal year that ended in Mar23 was $-0.040. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.13 for the trailing ten years ended in Mar23.

Shiller PE for Stocks: The True Measure of Stock Valuation


OKYO Pharma Cyclically Adjusted PB Ratio Historical Data

The historical data trend for OKYO Pharma's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OKYO Pharma Cyclically Adjusted PB Ratio Chart

OKYO Pharma Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 12.92

OKYO Pharma Semi-Annual Data
Sep13 Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 12.92

Competitive Comparison of OKYO Pharma's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, OKYO Pharma's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OKYO Pharma's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OKYO Pharma's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where OKYO Pharma's Cyclically Adjusted PB Ratio falls into.



OKYO Pharma Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

OKYO Pharma's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1.44/0.13
=11.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OKYO Pharma's Cyclically Adjusted Book per Share for the fiscal year that ended in Mar23 is calculated as:

For example, OKYO Pharma's adjusted Book Value per Share data for the fiscal year that ended in Mar23 was:

Adj_Book=Book Value per Share/CPI of Mar23 (Change)*Current CPI (Mar23)
=-0.04/126.8000*126.8000
=-0.040

Current CPI (Mar23) = 126.8000.

OKYO Pharma Annual Data

Book Value per Share CPI Adj_Book
201403 0.125 99.300 0.160
201503 0.089 99.600 0.113
201603 0.084 100.400 0.106
201703 0.180 102.700 0.222
201803 0.007 105.100 0.008
201903 0.001 107.000 0.001
202003 -0.014 108.600 -0.016
202103 0.514 109.700 0.594
202203 0.139 116.500 0.151
202303 -0.040 126.800 -0.040

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


OKYO Pharma  (NAS:OKYO) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


OKYO Pharma Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of OKYO Pharma's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


OKYO Pharma (OKYO Pharma) Business Description

Industry
Traded in Other Exchanges
Address
14/15 Conduit St, Floor 4, London, GBR, W1S 2XJ
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions on various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
Executives
John P Brancaccio director C/O TAMIR BIOTECHNOLOGY, INC., 11 DEER PARK DRIVE, SUITE 204, MONMOUTH JUNCTION NJ 08852
Gary S Jacob director, officer: Chief Executive Officer
Gabriele M Cerrone director, 10 percent owner, officer: Executive Chairman 265 EAST 66TH STREET, SUITE 16G, NEW YORK NY 10021
Bernard Denoyer director C/O CALLISTO PHARMACEUTICALS, INC., 420 LEXINGTON AVENUE, SUITE 1609, NEW YORK NY 10170
Willy Jules Simon director PLAYLOGIC INTERNATIONAL NV, CONCERTGEBOUWPLEIN 13, AMSTERDAM P7 1071 LL
Keeren Shah officer: Chief Financial Officer 55 PARK LANE, LONDON X0 W1K 1NA